AUTOLIV INC quarterly report, Q2 FY2019

Autoliv, Inc. — Q2 2019 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2019. Autoliv supplies automotive safety products, including airbags and seatbelts. Following the June 2018 spin-off, Veoneer is presented as discontinued operations; Autoliv retained certain legacy Electronics product, warranty, and recall obligations.

Financial results

  • Q2 revenue: $2.155 billion, down 2.6% year over year. Organic sales grew 1.5%, while currency reduced reported sales by 4.1%. Organic growth outperformed global light vehicle production, which fell 7.6%, by 9.1 percentage points.
  • Q2 product and regional trends: Airbag and other sales were nearly flat as reported, with 3.5% organic growth; seatbelt sales declined 7.1% as reported, including a 2.2% organic decline. Americas organic sales grew 11.5%; Europe fell 6.5%, China fell 2.6%, and Japan fell 1.4%.
  • Q2 earnings and margins: Gross profit was $399.7 million and gross margin was 18.6%, down 1.3 percentage points. Operating income was $169.5 million, down 26%; operating margin was 7.9%, down 2.5 points. Adjusted operating margin was 8.5%. Continuing-operations net income was $109.4 million; diluted EPS was $1.25, versus $2.20 a year earlier. Adjusted diluted EPS was $1.38, down 37.8%.
  • First-half results: Revenue was $4.329 billion, down 2.8% reported but up 1.6% organically. Gross margin was 18.0% versus 20.2%; operating income was $342.7 million versus $472.5 million. Continuing-operations net income was $220.9 million versus $352.3 million; diluted EPS was $2.52 versus $4.02.
  • Cash flow and investment: First-half operating cash flow was $133.1 million, compared with $63.0 million in 2018. Capital expenditures were $236.8 million, down from $306.4 million. Cash declined to $406.4 million from $615.8 million at year-end 2018. Dividends paid were $108.5 million.
  • Debt and liquidity: June 30 short- and long-term debt totaled $2.217 billion; net debt was $1.811 billion, versus $1.619 billion at year-end 2018. The leverage ratio was 1.8x, above the stated long-term target range of 0.5x–1.5x. The company refinanced some short-term obligations with a SEK 1.2 billion three-year loan and a EUR 100 million bond due December 2020.
  • Balance sheet: Current assets were $3.052 billion and current liabilities were $2.418 billion. Adoption of the lease standard added $165.0 million of operating lease right-of-use assets and $165.5 million of current and non-current lease liabilities at June 30.

Changes, outlook, and management commentary

  • Profitability weakened amid lower vehicle production, reduced factory utilization, high raw-material costs, elevated launch costs, and first-half costs associated with a labor conflict in Mexico. Q2 other income/expense also included accruals for workforce reductions and lower government income in China.
  • Management said it saw no near-term signs of a turnaround in vehicle demand and lowered its full-year 2019 outlook. The outlook assumed global light vehicle production would decline 4%–6%.
  • 2019 outlook: Organic sales growth of 1%–3%; consolidated sales growth of negative 1% to positive 1%; adjusted operating margin of 9%–9.5%; tax rate around 28%; operating cash flow of $700–$800 million excluding the EC antitrust payment and other unusual items; capital expenditures, net, below 2018 as a percentage of sales; and year-end leverage within 0.5x–1.5x. R&D expense, net, was expected to be lower than in 2018.
  • Cost actions included a Q2 workforce reduction of about 1,200, mainly temporary direct manufacturing workers, a planned reduction of indirect headcount by approximately 5%, and evaluation of further restructuring. Q2 capacity-alignment charges were $13.2 million. Western European restructuring programs had a $40.3 million total reserve, including about $27 million remaining for programs with aggregate expected costs of approximately $110 million.

Risks, contingencies, and unusual items

  • The European Commission imposed a €179 million (approximately $203 million) antitrust fine in March 2019; Autoliv paid it in June. The payment contributed to the higher leverage ratio. The company also faces antitrust civil litigation and notes that further investigations or proceedings could arise.
  • For the Toyota side-curtain-airbag recall involving approximately 1.4 million vehicles, the root-cause analysis remained ongoing. Autoliv considered a loss reasonably possible and estimated its net loss, after expected insurance recoveries, at less than $20 million if it is required to indemnify Toyota; ultimate costs could differ materially.
  • Product warranty, recall, and liability reserves were $55.9 million at June 30, including approximately $9 million of indemnification liabilities to Veoneer. Management believed reserves were adequate, but actual costs may differ and insurance may not cover all losses.
  • Q2 diluted EPS was affected by lower operating income, unusual tax items, and capacity-alignment and antitrust costs. The Q2 effective tax rate was 27.4%, versus 8.1% in 2018, when reversals of deferred-tax valuation allowances associated with the Veoneer spin-off benefited results.
  • Key risks include further vehicle-production weakness, raw-material cost pressure, customer and supplier dependence, currency movements, product claims and recalls, regulatory changes, and execution of restructuring and cost-reduction plans. Management reported effective disclosure controls and no material change in internal control over financial reporting.

Investor verification priorities

  1. Track vehicle-production trends, organic growth versus production, and progress toward the reduced full-year sales and margin outlook.
  2. Assess whether cost reductions and lower launch costs can offset weak utilization and raw-material pressures without compromising quality.
  3. Monitor cash generation, capital spending, debt maturities, and leverage against the 0.5x–1.5x year-end target.
  4. Verify the final financial and insurance exposure from the Toyota recall and any subsequent product claims.
  5. Review antitrust and restructuring cash costs, including the impact of the paid EC fine and remaining Western European obligations.